Search results

• Targeting toll-like receptor 2 and its crosstalk with the cystine/glutamate antiporter XCT as new combined therapy for breast cancer

  Author: Vanonckelen, O., Cavallo, F. & Massie, A., 23 May 2022

  Supervisor: Cavallo, F. (External person) (Promotor), Massie, A. (Promotor), Conti, L. (External person) (Co-promotor) & Di Lorenzo, A. (External person) (Advisor)

  Student thesis: Master's Thesis